Eli Samaha - 01 May 2024 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role: 10%+ Owner
Signature: Eli Samaha
Issuer symbol: TBPH
Transactions as of: 01 May 2024
Net transactions value: +$13,117,335
Form type: 4
Filing time: 03 May 2024, 16:19:22 UTC
Previous filing: 24 Oct 2023
Next filing: 04 Jun 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TBPH	COM	Purchase	$8,748,250	+999,800	+14%	$8.75	8,012,026	01 May 2024	See Footnote	F1
transaction	TBPH	COM	Purchase	$4,369,085	+499,324	+6.2%	$8.75	8,511,350	01 May 2024	See Footnote	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities.

Content

These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities.